Dr Colton Nielson, MD, FAAD, ACMS | |
800 S Church St Ste 103, Jonesboro, AR 72401-4154 | |
(870) 333-5145 | |
Not Available |
Full Name | Dr Colton Nielson |
---|---|
Gender | Male |
Speciality | Dermatology |
Experience | 7 Years |
Location | 800 S Church St Ste 103, Jonesboro, Arkansas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1699122507 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
St Bernards Medical Center | Jonesboro, AR | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
St Bernards Physician Clinics Inc | 7012311269 | 172 |
News Archive
When brain cells start oozing too much of the amyloid protein that is the hallmark of Alzheimer's disease, the astrocytes that normally nourish and protect them deliver a suicide package instead, researchers report.
Providing timely access to physiotherapy is a long-standing problem for the NHS, with more than 4 million new referrals each year and waiting times of several months in many areas. A Bristol-led study to improve access has been given £1.06 million by the Medical Research Council (MRC).
BIOLASE Technology, Inc., the world's leading dental laser company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Waterlase MD™ laser system for removal of subgingival calculi to prevent and treat periodontitis, the greatest cause of tooth loss for adults over 35 and a condition impacting more than half of Americans over the age of 55, as reported by the American Academy of Periodontology (AAP).
Pfizer has announced that the Austrian Patent Office has ruled that a claim in the company's basic patent covering the use of atorvastatin, the active ingredient in Lipitor, would be infringed by generic manufacturer Ranbaxy.
› Verified 3 days ago
Entity Name | Doctors Health Group, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1306366885 PECOS PAC ID: 7315844586 Enrollment ID: O20170830002507 |
News Archive
When brain cells start oozing too much of the amyloid protein that is the hallmark of Alzheimer's disease, the astrocytes that normally nourish and protect them deliver a suicide package instead, researchers report.
Providing timely access to physiotherapy is a long-standing problem for the NHS, with more than 4 million new referrals each year and waiting times of several months in many areas. A Bristol-led study to improve access has been given £1.06 million by the Medical Research Council (MRC).
BIOLASE Technology, Inc., the world's leading dental laser company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Waterlase MD™ laser system for removal of subgingival calculi to prevent and treat periodontitis, the greatest cause of tooth loss for adults over 35 and a condition impacting more than half of Americans over the age of 55, as reported by the American Academy of Periodontology (AAP).
Pfizer has announced that the Austrian Patent Office has ruled that a claim in the company's basic patent covering the use of atorvastatin, the active ingredient in Lipitor, would be infringed by generic manufacturer Ranbaxy.
› Verified 3 days ago
Entity Name | St Bernards Physician Clinics Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1447923438 PECOS PAC ID: 7012311269 Enrollment ID: O20210810001875 |
News Archive
When brain cells start oozing too much of the amyloid protein that is the hallmark of Alzheimer's disease, the astrocytes that normally nourish and protect them deliver a suicide package instead, researchers report.
Providing timely access to physiotherapy is a long-standing problem for the NHS, with more than 4 million new referrals each year and waiting times of several months in many areas. A Bristol-led study to improve access has been given £1.06 million by the Medical Research Council (MRC).
BIOLASE Technology, Inc., the world's leading dental laser company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Waterlase MD™ laser system for removal of subgingival calculi to prevent and treat periodontitis, the greatest cause of tooth loss for adults over 35 and a condition impacting more than half of Americans over the age of 55, as reported by the American Academy of Periodontology (AAP).
Pfizer has announced that the Austrian Patent Office has ruled that a claim in the company's basic patent covering the use of atorvastatin, the active ingredient in Lipitor, would be infringed by generic manufacturer Ranbaxy.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Colton Nielson, MD, FAAD, ACMS 800 S Church St Ste 103, Jonesboro, AR 72401-4154 Ph: (870) 333-5145 | Dr Colton Nielson, MD, FAAD, ACMS 800 S Church St Ste 103, Jonesboro, AR 72401-4154 Ph: (870) 333-5145 |
News Archive
When brain cells start oozing too much of the amyloid protein that is the hallmark of Alzheimer's disease, the astrocytes that normally nourish and protect them deliver a suicide package instead, researchers report.
Providing timely access to physiotherapy is a long-standing problem for the NHS, with more than 4 million new referrals each year and waiting times of several months in many areas. A Bristol-led study to improve access has been given £1.06 million by the Medical Research Council (MRC).
BIOLASE Technology, Inc., the world's leading dental laser company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Waterlase MD™ laser system for removal of subgingival calculi to prevent and treat periodontitis, the greatest cause of tooth loss for adults over 35 and a condition impacting more than half of Americans over the age of 55, as reported by the American Academy of Periodontology (AAP).
Pfizer has announced that the Austrian Patent Office has ruled that a claim in the company's basic patent covering the use of atorvastatin, the active ingredient in Lipitor, would be infringed by generic manufacturer Ranbaxy.
› Verified 3 days ago
Dr. Zachary Paul Nahmias, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4910 Medical Blvd, Jonesboro, AR 72405 Phone: 870-936-8000 Fax: 870-934-3623 | |
Dr. Mallory Hurst, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 800 S Church St Ste 202, Jonesboro, AR 72401 Phone: 870-336-0277 Fax: 870-932-5699 | |
David Howard Weingold, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 4334 E Highland Dr, Jonesboro, AR 72401 Phone: 870-802-3376 Fax: 870-972-5140 | |
Dr. Adam Ashley Sills, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1003 Windover Rd, Jonesboro, AR 72401 Phone: 870-336-1600 Fax: 870-336-0585 |